Watson, Not Par, Infringed Novartis Dementia Patch: Fed. Circ.
The Federal Circuit handed down a pair of rulings Thursday in infringement cases involving patents for Novartis Pharmaceuticals Corp.'s Exelon Patch, saying that a Par Pharmaceutical Inc. generic did not infringe...To view the full article, register now.
Already a subscriber? Click here to view full article